Stifel Nicolaus Issues Pessimistic Forecast for DocGo (NASDAQ:DCGO) Stock Price

DocGo (NASDAQ:DCGO) had its price objective reduced by Stifel Nicolaus from $6.50 to $5.50 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 77.99% from the stock’s current price.

Other research analysts also recently issued research reports about the stock. Needham & Company LLC decreased their price objective on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a “buy” rating to a “hold” rating and decreased their price objective for the company from $5.00 to $2.85 in a research report on Friday. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $4.89.

DocGo Price Performance

Shares of DCGO opened at $3.09 on Friday. The firm has a 50-day moving average of $4.58 and a 200-day moving average of $4.02. DocGo has a one year low of $2.75 and a one year high of $5.68. The company has a market cap of $315.34 million, a PE ratio of 11.04, a price-to-earnings-growth ratio of 14.16 and a beta of 1.00.

Insider Transactions at DocGo

In other news, General Counsel Ely D. Tendler sold 23,088 shares of the firm’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the sale, the general counsel now owns 175,645 shares in the company, valued at approximately $779,863.80. This trade represents a 11.62 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 2.70% of the stock is currently owned by corporate insiders.

Institutional Trading of DocGo

A number of hedge funds have recently modified their holdings of DCGO. Centiva Capital LP acquired a new stake in shares of DocGo during the 3rd quarter worth about $43,000. Summit Investment Advisors Inc. raised its stake in DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after purchasing an additional 2,968 shares in the last quarter. Prudential Financial Inc. acquired a new stake in DocGo in the 4th quarter worth about $55,000. Intech Investment Management LLC acquired a new stake in DocGo in the 3rd quarter worth about $62,000. Finally, Royce & Associates LP acquired a new stake in DocGo in the 4th quarter worth about $64,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.